FDA and AI: tools and rules for medical device teams

“FDA AI” means two things to a device team: AI tools that help prepare FDA submissions, and the rules FDA applies to medical devices that use AI. For the first, choose tools that cite FDA’s own records, such as Bearnier AI, and check every fact; for the second, FDA reviews AI-enabled devices through the same 510(k), De Novo and PMA pathways as other devices, and lets a submission include a predetermined change control plan for planned model updates.
Written by the Bearnier AI team · Updated Oct 16, 2026

Ask about FDA and your device

Bearnier AI answers from FDA’s records, with every precise fact cited to its page.

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about FDA and AI

What does “FDA AI” mean for a device company?

Usually one of two things: AI tools that help prepare FDA submissions, such as predicate and testing research, or how FDA regulates medical devices that use AI. This page links to both.

How does FDA regulate AI-enabled medical devices?

As medical devices: FDA says it does not regulate AI as such. AI-enabled devices go through the 510(k), De Novo or PMA pathway, and a submission can include a predetermined change control plan for planned modifications.

How many AI-enabled devices has FDA authorized?

FDA says over 1,600 as of September 2026. Its public list held 1,614 entries when we read it on Nov 16, 2026.

Which AI tool should I use for an FDA submission?

One that searches FDA’s own records and links every precise fact to its page, so you can check it. Bearnier AI does this for the US FDA device record; FDA’s free databases are the baseline; general assistants are for concepts and drafting.

Sources

  1. Artificial Intelligence-Enabled Medical Devices · FDA, content current as of Sep 22, 2026
  2. List of Artificial Intelligence-Enabled Medical Devices · FDA, content current as of Sep 4, 2026
  3. Marketing Submission Recommendations for a Predetermined Change Control Plan for Artificial Intelligence-Enabled Device Software Functions · FDA final guidance, issued Aug 18, 2025 (first issued Dec 4, 2024) · docket FDA-2022-D-2628
  4. Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations · FDA draft guidance, Jan 7, 2025, not for implementation · docket FDA-2024-D-4488
  5. Premarket Notification 510(k) · FDA, content current as of Aug 22, 2024
  6. De Novo Classification Request · FDA
  7. Premarket Approval (PMA) · FDA
  8. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
  9. Product Classification database · FDA, accessdata.fda.gov

Know what FDA already cleared.